Journal Title：Lung Cancer-targets And Therapy

Lung Cancer - Targets and Therapy is a peer-reviewed open access journal dedicated to the treatment goals and therapies for lung cancer. This journal covers multiple aspects such as lung cancer diagnosis, molecular targeted therapy, immunotherapy, drug development, clinical trials, and basic scientific research related to treatment. It aims to provide a platform for lung cancer researchers, clinical doctors, and other healthcare professionals to exchange the latest research findings and treatment strategies.

The magazine has had a significant impact on the scientific development and clinical practice of lung cancer treatment by publishing high-quality research articles. The open access policy of journals promotes knowledge sharing globally and accelerates the translation of research results into clinical applications. It is an authoritative resource in the field of lung cancer research and treatment, providing professionals with a timely channel to stay informed about the latest research trends and treatment strategies. By reading this journal, medical professionals can gain valuable information for improving patient care and advancing the discipline.

《肺癌-靶點(diǎn)和治療》是一本專注于肺癌治療目標(biāo)和療法的同行評審開放獲取期刊。該期刊涵蓋了肺癌診斷、分子靶向治療、免疫治療、藥物開發(fā)、臨床試驗(yàn)以及治療相關(guān)的基礎(chǔ)科學(xué)研究等多個(gè)方面。它旨在為肺癌研究人員、臨床醫(yī)生和其他醫(yī)療保健專業(yè)人員提供一個(gè)交流最新研究成果和治療策略的平臺。

雜志通過發(fā)表高質(zhì)量的研究文章，對肺癌治療領(lǐng)域的科學(xué)發(fā)展和臨床實(shí)踐產(chǎn)生了重要影響。期刊的開放獲取政策促進(jìn)了全球范圍內(nèi)的知識共享，加速了研究成果向臨床應(yīng)用的轉(zhuǎn)化。它是肺癌研究和治療領(lǐng)域的權(quán)威資源，它為專業(yè)人士提供了一個(gè)及時(shí)了解最新研究趨勢和治療策略的渠道。通過閱讀該期刊，醫(yī)療專業(yè)人員可以獲得寶貴的信息，用于改善患者護(hù)理和推動(dòng)學(xué)科前進(jìn)。

Lung Cancer-targets And Therapy由Dove Medical Press出版商出版，收稿方向涵蓋ONCOLOGY全領(lǐng)域，平均審稿速度 16 Weeks ，影響因子指數(shù)5.1，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。